Wilson Asset Management International PTY Ltd. Increases Stock Position in Masimo Corporation $MASI

Key Points

• Wilson Asset Management International boosted its Masimo stake by 44.8% in Q4, adding 12,203 shares to hold 39,437 shares (~$5.13M), making MASI its 23rd-largest holding and ~1.3% of the firm's portfolio.
• Institutional ownership is substantial at 85.96%, with several other funds either initiating small positions or modestly increasing exposure to Masimo during the latest quarters.
• Analyst sentiment is cautious: the MarketBeat consensus is "Reduce" with a $181.17 target, and multiple firms have recently downgraded MASI while the stock trades near its one-year high around $178–179.

Wilson Asset Management International PTY Ltd. grew its stake in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 44.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 39,437 shares of the medical equipment provider's stock after buying an additional 12,203 shares during the period. Masimo accounts for 1.3% of Wilson Asset Management International PTY Ltd.'s investment portfolio, making the stock its 23rd biggest position. Wilson Asset Management International PTY Ltd. owned approximately 0.07% of Masimo worth $5,129,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Torren Management LLC purchased a new position in Masimo during the fourth quarter worth $35,000. Smartleaf Asset Management LLC increased its position in Masimo by 80.0% during the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider's stock worth $44,000 after buying an additional 136 shares in the last quarter. Advisory Services Network LLC purchased a new position in Masimo during the third quarter worth $46,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Masimo during the fourth quarter worth about $44,000. Finally, Danske Bank A S purchased a new stake in shares of Masimo during the third quarter worth about $59,000. Hedge funds and other institutional investors own 85.96% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on MASI shares. Weiss Ratings reiterated a "sell (d)" rating on shares of Masimo in a report on Thursday, January 22nd. Piper Sandler downgraded shares of Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price target for the company. in a report on Tuesday, February 17th. Raymond James Financial downgraded shares of Masimo from an "outperform" rating to a "market perform" rating in a report on Friday, March 27th. Wolfe Research downgraded shares of Masimo from a "strong-buy" rating to a "hold" rating in a report on Thursday, February 19th. Finally, Stifel Nicolaus set a $180.00 price target on shares of Masimo in a report on Tuesday, February 17th. Eight analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Masimo currently has a consensus rating of "Reduce" and a consensus target price of $181.17.

Masimo Price Performance

Masimo stock opened at $178.58 on Wednesday. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.00. The firm has a 50 day moving average price of $177.28 and a 200 day moving average price of $154.19. The company has a market cap of $9.32 billion, a price-to-earnings ratio of -16.94, a PEG ratio of 1.81 and a beta of 1.13. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49.

Masimo Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.